PD-1 blockade in tumors with mismatch-repair deficiency
- 23 June 2015
- journal article
- Published by Lavoisier in Côlon & Rectum
- Vol. 9 (3), 182-184
- https://doi.org/10.1007/s11725-015-0588-4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trialThe Lancet, 2014
- Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patientsDigestive and Liver Disease, 2013
- Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics AnalysisPLOS ONE, 2010
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- High Prevalence of Activated Intraepithelial Cytotoxic T Lymphocytes and Increased Neoplastic Cell Apoptosis in Colorectal Carcinomas with Microsatellite InstabilityThe American Journal of Pathology, 1999